Pralatrexate
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 226 publications
Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.
Journal: BMJ case reports
Published: June 23, 2026
Pralatrexate is a potent pan-serotype human adenovirus inhibitor through suppression of dihydrofolate reductase.
Journal: Antimicrobial agents and chemotherapy
Published: May 28, 2026
Beyond Romidepsin: Novel Therapeutic Targets and Emerging Strategies for Relapsed and Refractory Peripheral T-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 21, 2026
Primary Cutaneous Gamma-Delta T-Cell Lymphoma Complicating Long-Standing Immunosuppressed Dermatomyositis.
Journal: Journal of cutaneous pathology
Published: April 03, 2026
Pasta, a Versatile Transcriptomic Clock, Maps the Chemical and Genetic Determinants of Aging and Rejuvenation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 23, 2026
In silico discovery of novel small-molecule PD-L1 inhibitors through a multi-stage computational workflow integrating machine learning and molecular dynamics.
Journal: Journal of computer-aided molecular design
Published: February 04, 2026
Lipocalin 2 as a novel target of pralatrexate mitigating corneal epithelial damage in a mouse model of herpes simplex keratitis.
Journal: The ocular surface
Published: January 12, 2026
Real-world pharmacovigilance analysis of pralatrexate using the FDA adverse event reporting system database.
Journal: Frontiers in pharmacology
Published: December 22, 2025
Pembrolizumab and pralatrexate for relapsed or refractory peripheral T-cell lymphomas.
Journal: British journal of haematology
Published: December 22, 2025
Integrating functional genomics and proteomics identifies Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in T-cell lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Subcutaneous panniculitis-like T-cell lymphoma complicated by hemophagocytic syndrome with significant response to pralatrexate: A case report.
Journal: JAAD case reports
Published: November 10, 2025
Functional genomics and proteomics identify Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in diverse T-cell lymphoma models.
Journal: Molecular cancer therapeutics
Published: October 21, 2025
Last Updated: 09/26/2026